Last 12 months
Inside the activity.
8 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 3 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 2 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 20, 2026 Filed Sep 8, 2026 14:55 UTC |
MOORE JOHN ADirector · Chairman of the Board
|
PurchaseCommon Stock | 5,000 | $0.76 | $3,800.00 |
DisclosureSEC source: 0001182944-26-000006 · primary_doc.xml · nonDerivative · entry 1 MOORE JOHN A · CIK 0001182944 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 950,641 Read SEC document |
| August 20, 2026 Filed Aug 20, 2026 17:36 UTC |
MOORE JOHN ADirector · Chairman of the Board
|
PurchaseCommon Stock | 14,700 | $0.71 | $10,454.64 |
DisclosureSEC source: 0001182944-26-000005 · primary_doc.xml · nonDerivative · entry 1 MOORE JOHN A · CIK 0001182944 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 945,641 Read SEC document |
| June 02, 2026 Filed Jun 18, 2026 20:01 UTC |
MOORE JOHN ADirector · Chairman of the Board
|
PurchaseCommon Stock | 4,000 | $0.71 | $2,845.20 |
DisclosureSEC source: 0001182944-26-000004 · primary_doc.xml · nonDerivative · entry 1 MOORE JOHN A · CIK 0001182944 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 930,871 Read SEC document |
| March 23, 2026 Filed Mar 24, 2026 17:00 UTC |
MOORE JOHN ADirector · Chairman
|
PurchaseCommon Stock | 9,000 | $0.58 | $5,220.00 |
DisclosureSEC source: 0001182944-26-000003 · primary_doc.xml · nonDerivative · entry 1 MOORE JOHN A · CIK 0001182944 · Director · Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 926,871 Read SEC document |
| February 19, 2026 Filed Mar 17, 2026 19:30 UTC |
MOORE JOHN ADirector · Chairman of the Board
|
PurchaseCommon Stock | 1,000 | $0.65 | $650.00 |
DisclosureSEC source: 0001182944-26-000002 · primary_doc.xml · nonDerivative · entry 1 MOORE JOHN A · CIK 0001182944 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 917,871 Read SEC document |
| February 17, 2026 Filed Mar 17, 2026 21:22 UTC |
Rovinsky ZacharyChief Financial Officer
|
GrantStock Option · Derivative | 25,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0002092274-26-000003 · primary_doc.xml · derivative · entry 1 Rovinsky Zachary · CIK 0002092274 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 25,000 shares Expires 2036-02-17 F1 · derivative.exercise_date: Vesting is based on 4 year cliff from date of option grant. Read SEC document |
| February 17, 2026 Filed Mar 17, 2026 19:41 UTC |
BLECHMAN MICHAELDirector
|
GrantStock Option · Derivative | 20,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0002021300-26-000001 · primary_doc.xml · derivative · entry 2 BLECHMAN MICHAEL · CIK 0002021300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,186 Underlying: Common Stock · 20,000 shares Expires 2036-02-17 Read SEC document |
| February 17, 2026 Filed Mar 17, 2026 19:41 UTC |
BLECHMAN MICHAELDirector
|
GrantStock Option · Derivative | 24,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0002021300-26-000001 · primary_doc.xml · derivative · entry 1 BLECHMAN MICHAEL · CIK 0002021300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,186 Underlying: Common Stock · 24,000 shares Expires 2036-02-17 F1 · derivative.exercise_date: Options granted to Registrant in lieu of cash fees. Vesting 1 year - 1/12th per month. Read SEC document |
| February 17, 2026 Filed Mar 17, 2026 19:27 UTC |
MOORE JOHN ADirector · Chairman of the Board
|
GrantStock Option · Derivative | 30,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001182944-26-000001 · primary_doc.xml · derivative · entry 2 MOORE JOHN A · CIK 0001182944 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 916,871 Underlying: Common Stock · 30,000 shares Expires 2036-02-17 Read SEC document |
| February 17, 2026 Filed Mar 17, 2026 19:27 UTC |
MOORE JOHN ADirector · Chairman of the Board
|
GrantStock Option · Derivative | 230,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001182944-26-000001 · primary_doc.xml · derivative · entry 1 MOORE JOHN A · CIK 0001182944 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 886,871 Underlying: Common Stock · 230,000 shares Expires 2036-02-17 F1 · derivative.exercise_date: Options granted to Registrant in lieu of cash compensation. Vesting is 1 year - 1/12th per month. Read SEC document |
| February 17, 2026 Filed Mar 17, 2026 18:46 UTC |
NICOLS JOHN JDirector
|
GrantStock Option · Derivative | 20,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001238884-26-000001 · primary_doc.xml · derivative · entry 2 NICOLS JOHN J · CIK 0001238884 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 275,778 Underlying: Common Stock · 20,000 shares Expires 2036-02-17 F1 · derivative.exercise_date: On 2/17/26 Registrant was awarded stock options in lieu of cash fees. Vesting 1 Year - 1/12th per month. Read SEC document |
| February 17, 2026 Filed Mar 17, 2026 18:46 UTC |
NICOLS JOHN JDirector
|
GrantStock Option · Derivative | 120,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001238884-26-000001 · primary_doc.xml · derivative · entry 1 NICOLS JOHN J · CIK 0001238884 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 255,778 Underlying: Common Stock · 120,000 shares Expires 2036-02-17 F1 · derivative.exercise_date: On 2/17/26 Registrant was awarded stock options in lieu of cash fees. Vesting 1 Year - 1/12th per month. Read SEC document |
| February 17, 2026 Filed Apr 1, 2026 16:06 UTC |
SANTOS HELENA RDirector · President and CEO
|
GrantStock Option · Derivative | 130,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001286205-26-000004 · primary_doc.xml · derivative · entry 1 SANTOS HELENA R · CIK 0001286205 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 563,388 Underlying: Common Stock · 130,000 shares Expires 2036-02-17 F1 · derivative.exercise_date: Vesting is based on 4 year cliff from date of option grant. Read SEC document |
| February 17, 2026 Filed Apr 1, 2026 16:02 UTC |
SANTOS HELENA RDirector · President and CEO
|
GrantStock Option · Derivative | 50,000 | Not disclosed Strike: $0.60 | Not disclosed |
DisclosureSEC source: 0001286205-26-000003 · primary_doc.xml · derivative · entry 1 SANTOS HELENA R · CIK 0001286205 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 433,388 Underlying: Common Stock · 50,000 shares Expires 2036-02-17 F1 · price: Options granted to Registrant in lieu of salary. Vesting 1 year - 1/12th per month. F1 · derivative.exercise_date: Options granted to Registrant in lieu of salary. Vesting 1 year - 1/12th per month. Read SEC document |
| December 17, 2025 Filed Dec 18, 2025 21:13 UTC |
MOORE JOHN ADirector · Chairman
|
PurchaseCommon Stock | 6,500 | $0.53 | $3,454.75 |
DisclosureSEC source: 0001182944-25-000009 · primary_doc.xml · nonDerivative · entry 1 MOORE JOHN A · CIK 0001182944 · Director · Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 663,371 Read SEC document |
| December 17, 2025 Filed Dec 18, 2025 21:09 UTC |
MOORE JOHN ADirector · Chairman
|
PurchaseCommon Stock | 11,700 | $0.54 | $6,358.95 |
DisclosureSEC source: 0001182944-25-000008 · primary_doc.xml · nonDerivative · entry 1 MOORE JOHN A · CIK 0001182944 · Director · Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 656,871 Read SEC document |
| December 05, 2025 Filed Dec 15, 2025 21:36 UTC |
MOORE JOHN ADirector · Chairman
|
PurchaseCommon Stock | 20,000 | $0.60 | $12,096.00 |
DisclosureSEC source: 0001182944-25-000007 · primary_doc.xml · nonDerivative · entry 1 MOORE JOHN A · CIK 0001182944 · Director · Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 645,171 Read SEC document |
| September 17, 2025 Filed Sep 18, 2025 20:51 UTC |
MOORE JOHN ADirector · Chairman of the Board
|
PurchaseCommon Stock | 5,800 | $0.70 | $4,060.00 |
DisclosureSEC source: 0001182944-25-000006 · primary_doc.xml · nonDerivative · entry 1 MOORE JOHN A · CIK 0001182944 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 467,089 Read SEC document |
| September 16, 2025 Filed Sep 18, 2025 20:47 UTC |
MOORE JOHN ADirector
|
PurchaseCommon Stock | 9,599 | $0.64 | $6,143.36 |
DisclosureSEC source: 0001182944-25-000005 · primary_doc.xml · nonDerivative · entry 1 MOORE JOHN A · CIK 0001182944 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 461,289 Read SEC document |
| August 20, 2025 Filed Sep 4, 2025 19:57 UTC |
MOORE JOHN ADirector
|
GrantCommon Stock | 30,000 | $1.00 | $30,000.00 |
DisclosureSEC source: 0001182944-25-000004 · primary_doc.xml · nonDerivative · entry 1 MOORE JOHN A · CIK 0001182944 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 451,690 F1 · price: On August 20, 2025, 30,000 warrants for 30,000 shares of the Company's common stock were exercised at $1.00 per share. Read SEC document |
| August 20, 2025 Filed Sep 9, 2025 17:07 UTC |
BLECHMAN MICHAELDirector
|
GrantCommon Stock | 10,000 | $1.00 | $10,000.00 |
DisclosureSEC source: 0002021300-25-000003 · primary_doc.xml · nonDerivative · entry 1 BLECHMAN MICHAEL · CIK 0002021300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,186 F1 · price: On August 20, 2025, 10,000 warrants for 10,000 shares of the Company's Common Stock were exercised at $1.00 per share. Read SEC document |
| August 20, 2025 Filed Oct 6, 2025 16:27 UTC |
NICOLS JOHN JDirector
|
GrantCommon Stock | 15,000 | $1.00 | $15,000.00 |
DisclosureSEC source: 0001238884-25-000005 · primary_doc.xml · nonDerivative · entry 1 NICOLS JOHN J · CIK 0001238884 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,778 F1 · price: On August 20, 2025 15,000 warrants for 15,000 shares of the Company's common stock were exercised at $1.00 per share. Read SEC document |
| May 13, 2025 Filed May 22, 2025 18:16 UTC |
MOORE JOHN ADirector · Chairman of the Board
|
GrantStock Option · Derivative | 65,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001182944-25-000003 · primary_doc.xml · derivative · entry 1 MOORE JOHN A · CIK 0001182944 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 451,690 Underlying: Common Stock · 65,000 shares Expires 2035-05-13 F1 · derivative.exercise_date: 1/4 of the option shares vest one year from issue date, the balance of the shares vest in a series of thirty six (36) equal monthly installments measured from the first anniversary date of the issue date. Read SEC document |
| May 13, 2025 Filed May 23, 2025 16:03 UTC |
SANTOS HELENA RDirector · Chief Executive Officer
|
GrantStock Option · Derivative | 70,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001286205-25-000002 · primary_doc.xml · derivative · entry 1 SANTOS HELENA R · CIK 0001286205 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 359,443 Underlying: Common Stock · 70,000 shares Expires 2035-05-13 F1 · derivative.exercise_date: 1/4 of the option shares vest one year from issue date, the balance of the shares vest in a series of thirty six (36) equal monthly installments measured from the first anniversary date of the issue date. Read SEC document |
| April 18, 2025 Filed Apr 22, 2025 21:50 UTC |
Bleichroeder LP10% owner
|
PurchaseWarrants to Purchase Common Stock · Derivative | 250,000 | Not disclosed Strike: $1.00 | Not disclosed |
DisclosureSEC source: 0001781002-25-000004 · primary_doc.xml · derivative · entry 2 Bleichroeder LP · CIK 0001781002 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2025-10-18 F1 · kind: On April 18, 2025, 21 April Fund, Ltd. and 21 April Fund, LP agreed to purchase from Scientific Industries Inc. (the "Issuer"), for an aggregate purchase price of $250,000, 250,000 shares of Common Stock and warrants to acquire 250,000 shares of Common Stock at an exercise price of $1.00 per share. F1 · price: On April 18, 2025, 21 April Fund, Ltd. and 21 April Fund, LP agreed to purchase from Scientific Industries Inc. (the "Issuer"), for an aggregate purchase price of $250,000, 250,000 shares of Common Stock and warrants to acquire 250,000 shares of Common Stock at an exercise price of $1.00 per share. F2 · ownership.nature: This form is filed by Bleichroeder LP. Bleichroeder LP serves as registered investment adviser to 21 April Fund, Ltd., 21 April Fund, LP and other managed accounts. Bleichroeder LP disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder LP is the beneficial owner of the securities for purposes of Section 16 or for any other purposes. Read SEC document |
| April 18, 2025 Filed Apr 22, 2025 21:50 UTC |
Bleichroeder LP10% owner
|
PurchaseCommon Stock | 250,000 | $1.00 | $250,000.00 |
DisclosureSEC source: 0001781002-25-000004 · primary_doc.xml · nonDerivative · entry 1 Bleichroeder LP · CIK 0001781002 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,453,351 F1 · price: On April 18, 2025, 21 April Fund, Ltd. and 21 April Fund, LP agreed to purchase from Scientific Industries Inc. (the "Issuer"), for an aggregate purchase price of $250,000, 250,000 shares of Common Stock and warrants to acquire 250,000 shares of Common Stock at an exercise price of $1.00 per share. F2 · ownership.nature: This form is filed by Bleichroeder LP. Bleichroeder LP serves as registered investment adviser to 21 April Fund, Ltd., 21 April Fund, LP and other managed accounts. Bleichroeder LP disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder LP is the beneficial owner of the securities for purposes of Section 16 or for any other purposes. Read SEC document |
| April 18, 2025 Filed May 15, 2025 20:46 UTC |
NICOLS JOHN JDirector
|
PurchaseWarrant to Purchase Common Stock · Derivative | 15,000 | Not disclosed Strike: $1.00 | Not disclosed |
DisclosureSEC source: 0001238884-25-000001 · primary_doc.xml · derivative · entry 2 NICOLS JOHN J · CIK 0001238884 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,778 Underlying: Common Stock · 15,000 shares Expires 2025-10-18 F1 · price: On April 18, 2025 Registrant purchased from Scientific Industries, Inc. (the "Issuer") for an aggregate purchase price of $15,000, 15,000 shares of Common Stock and warrants to acquire 15,000 shares of Common Stock at an exercise price of $1.00 per share. Read SEC document |
| April 18, 2025 Filed May 15, 2025 20:46 UTC |
NICOLS JOHN JDirector
|
PurchaseCommon Stock | 15,000 | $1.00 | $15,000.00 |
DisclosureSEC source: 0001238884-25-000001 · primary_doc.xml · nonDerivative · entry 1 NICOLS JOHN J · CIK 0001238884 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Read SEC document |
| April 18, 2025 Filed May 19, 2025 18:43 UTC |
MOORE JOHN ADirector · Chairman of the Board
|
PurchaseWarrant to Purchase Common Stock · Derivative | 35,000 | Not disclosed Strike: $1.00 | Not disclosed |
DisclosureSEC source: 0001182944-25-000002 · primary_doc.xml · derivative · entry 2 MOORE JOHN A · CIK 0001182944 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 386,690 Underlying: Common Stock · 35,000 shares Expires 2025-10-18 F1 · price: On April 18, 2025 Registrant purchased from Scientific Industries, Inc. (the "Issuer") for an aggregate purchase price of $35,000, 35,000 shares of Common Stock and warrants to acquire 35,000 shares of Common Stock at an exercise price of $1.00 per share. Read SEC document |
| April 18, 2025 Filed May 19, 2025 18:43 UTC |
MOORE JOHN ADirector · Chairman of the Board
|
PurchaseCommon Stock | 35,000 | $1.00 | $35,000.00 |
DisclosureSEC source: 0001182944-25-000002 · primary_doc.xml · nonDerivative · entry 1 MOORE JOHN A · CIK 0001182944 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,782 Read SEC document |
| April 18, 2025 Filed May 19, 2025 17:34 UTC |
BLECHMAN MICHAELDirector
|
PurchaseWarrants to Purchase Common Stock · Derivative | 10,000 | Not disclosed Strike: $1.00 | Not disclosed |
DisclosureSEC source: 0002021300-25-000002 · primary_doc.xml · derivative · entry 2 BLECHMAN MICHAEL · CIK 0002021300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,186 Underlying: Common Stock · 10,000 shares Expires 2025-10-18 F1 · price: On April 18, 2025 Registrant purchased from Scientific Industries, Inc. (the "Issuer") for an aggregate purchase price of $10,000, 10,000 shares of Common Stock and warrants to acquire 10,000 shares of Common Stock at an exercise price of $1.00 per share. Read SEC document |
| April 18, 2025 Filed May 19, 2025 17:34 UTC |
BLECHMAN MICHAELDirector
|
PurchaseCommon Stock | 10,000 | $1.00 | $10,000.00 |
DisclosureSEC source: 0002021300-25-000002 · primary_doc.xml · nonDerivative · entry 1 BLECHMAN MICHAEL · CIK 0002021300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| October 31, 2024 Filed Oct 31, 2024 21:00 UTC |
MOORE JOHN ADirector · Chairman of the Board
|
PurchaseCommon Stock | 7,000 | $0.97 | $6,755.00 |
DisclosureSEC source: 0001182944-24-000008 · primary_doc.xml · nonDerivative · entry 1 MOORE JOHN A · CIK 0001182944 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 479,772 F1 · balance_after: Includes 128,082 shares of Common Stock, 286,134 Options to Purchase Common Stock, and 65,556 Warrants to Purchase Common Stock. Read SEC document |
| July 01, 2024 Filed Aug 2, 2024 21:19 UTC |
Cox Christopher TDirector
|
GrantOption to Purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0001557341-24-000005 · primary_doc.xml · derivative · entry 2 Cox Christopher T · CIK 0001557341 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 334,209 Underlying: Common stock · 5,000 shares Expires 2034-07-01 Read SEC document |
| July 01, 2024 Filed Aug 2, 2024 21:19 UTC |
Cox Christopher TDirector
|
GrantOption to Purchase Common stock · Derivative | 10,000 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0001557341-24-000005 · primary_doc.xml · derivative · entry 1 Cox Christopher T · CIK 0001557341 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 329,209 Underlying: Common Stock · 10,000 shares Expires 2034-07-01 Read SEC document |
| July 01, 2024 Filed Aug 2, 2024 21:02 UTC |
SCHUMACHER JURGEN WALTERDirector
|
GrantOption to Purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0001987646-24-000002 · primary_doc.xml · derivative · entry 1 SCHUMACHER JURGEN WALTER · CIK 0001987646 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,502 Underlying: Common Stock · 10,000 shares Expires 2034-07-01 Read SEC document |
| July 01, 2024 Filed Aug 2, 2024 20:26 UTC |
NICOLS JOHN JDirector
|
GrantOption to Purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0001238884-24-000005 · primary_doc.xml · derivative · entry 2 NICOLS JOHN J · CIK 0001238884 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,778 Underlying: Common Stock · 5,000 shares Expires 2034-07-01 Read SEC document |
| July 01, 2024 Filed Aug 2, 2024 20:26 UTC |
NICOLS JOHN JDirector
|
GrantOption to Purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0001238884-24-000005 · primary_doc.xml · derivative · entry 1 NICOLS JOHN J · CIK 0001238884 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,778 Underlying: Common Stock · 10,000 shares Expires 2034-07-01 Read SEC document |
| July 01, 2024 Filed Aug 2, 2024 20:38 UTC |
BLECHMAN MICHAELDirector
|
GrantOption to Purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0002021300-24-000003 · primary_doc.xml · derivative · entry 1 BLECHMAN MICHAEL · CIK 0002021300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,186 Underlying: Common Stock · 5,000 shares Expires 2034-07-01 Read SEC document |
| June 13, 2024 Filed Jun 13, 2024 21:18 UTC |
MOORE JOHN ADirector
|
PurchaseCommon Stock | 9,200 | $1.43 | $13,192.80 |
DisclosureSEC source: 0001182944-24-000006 · primary_doc.xml · nonDerivative · entry 2 MOORE JOHN A · CIK 0001182944 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 414,590 Read SEC document |
| June 13, 2024 Filed Jun 13, 2024 21:18 UTC |
MOORE JOHN ADirector
|
PurchaseCommon Stock | 7,100 | $1.53 | $10,841.70 |
DisclosureSEC source: 0001182944-24-000006 · primary_doc.xml · nonDerivative · entry 1 MOORE JOHN A · CIK 0001182944 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 405,390 Read SEC document |
| May 17, 2024 Filed Jun 27, 2024 14:44 UTC |
BLECHMAN MICHAELDirector
|
GrantOptions to Purchase Common Stock · Derivative | 7,186 | Not disclosed Strike: $2.50 | Not disclosed |
DisclosureSEC source: 0002021300-24-000002 · primary_doc.xml · derivative · entry 2 BLECHMAN MICHAEL · CIK 0002021300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,186 Underlying: Common Stock · 7,186 shares Expires 2034-05-17 F2 · price: On May 17, 2024 the Reporting Person and the Issuer entered into an agreement to elect to be paid part of his fees in lieu of cash compensation. These options vest in twelve monthly installments commencing on May 17, 2024 through May 17, 2025. F2 · derivative.exercise_date: On May 17, 2024 the Reporting Person and the Issuer entered into an agreement to elect to be paid part of his fees in lieu of cash compensation. These options vest in twelve monthly installments commencing on May 17, 2024 through May 17, 2025. Read SEC document |
| May 17, 2024 Filed Jun 27, 2024 14:44 UTC |
BLECHMAN MICHAELDirector
|
GrantOptions to Purchase Common Stock · Derivative | 25,000 | $0.00 Strike: $1.75 | $0.00 |
DisclosureSEC source: 0002021300-24-000002 · primary_doc.xml · derivative · entry 1 BLECHMAN MICHAEL · CIK 0002021300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2034-05-17 F1 · derivative.exercise_date: Options vest in three successive equal installments from 5/17/24 as to 1/3 on each of the first, second, and third anniversaries. Read SEC document |
| April 01, 2024 Filed Jun 20, 2024 16:39 UTC |
MOORE JOHN ADirector
|
GrantOptions to Purchase Common Stock · Derivative | 58,182 | Not disclosed Strike: $2.50 | Not disclosed |
DisclosureSEC source: 0001182944-24-000007 · primary_doc.xml · derivative · entry 1 MOORE JOHN A · CIK 0001182944 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 351,690 Underlying: Common Stocck · 58,182 shares Expires 2034-04-01 F1 · price: On April 1, 2024 the Reporting Person and the Issuer entered into an agreement to elect to be paid part of his salary in stock options in lieu of cash compensation. These options vest in twelve monthly installments commencing on April 1, 2024 through April 1, 2025. F1 · derivative.exercise_date: On April 1, 2024 the Reporting Person and the Issuer entered into an agreement to elect to be paid part of his salary in stock options in lieu of cash compensation. These options vest in twelve monthly installments commencing on April 1, 2024 through April 1, 2025. F2 · balance_after: Includes 65,556 Warrants to Purchase Common Stock, and 286,134 Options to Purchase Common Stock. Read SEC document |
| April 01, 2024 Filed Jun 27, 2024 14:25 UTC |
SANTOS HELENA RDirector · CEO and President
|
GrantOptions to Purchase Common Stock · Derivative | 55,100 | Not disclosed Strike: $2.50 | Not disclosed |
DisclosureSEC source: 0001286205-24-000001 · primary_doc.xml · derivative · entry 1 SANTOS HELENA R · CIK 0001286205 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 289,443 Underlying: Common Stock · 55,100 shares Expires 2034-04-01 F1 · price: On April 1, 2024, the Reporting Person and the Issuer entered into an agreement whereby the Reporting Person elected to be paid part of her salary in stock options in lieu of cash compensation. These options vest in twelve monthly installments commencing on April 1, 2024 through April 1, 2025. F1 · derivative.exercise_date: On April 1, 2024, the Reporting Person and the Issuer entered into an agreement whereby the Reporting Person elected to be paid part of her salary in stock options in lieu of cash compensation. These options vest in twelve monthly installments commencing on April 1, 2024 through April 1, 2025. Read SEC document |
| April 01, 2024 Filed Jun 28, 2024 21:22 UTC |
Cox Christopher TDirector
|
GrantOptions to Purchase Common Stock · Derivative | 17,964 | Not disclosed Strike: $2.50 | Not disclosed |
DisclosureSEC source: 0001557341-24-000004 · primary_doc.xml · derivative · entry 1 Cox Christopher T · CIK 0001557341 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 319,209 Underlying: Common Stock · 17,964 shares Expires 2034-04-01 F1 · price: On April 1, 2024 the Reporting Person and the Issuer entered into an agreement to elect to be paid for Reporting Person's fees as a Board Director in stock options in lieu of cash compensation. These options vest in twelve (12) monthly installments commencing on April 1, 2024 through April 1, 2025. F1 · derivative.exercise_date: On April 1, 2024 the Reporting Person and the Issuer entered into an agreement to elect to be paid for Reporting Person's fees as a Board Director in stock options in lieu of cash compensation. These options vest in twelve (12) monthly installments commencing on April 1, 2024 through April 1, 2025. Read SEC document |
| April 01, 2024 Filed Jul 1, 2024 14:41 UTC | GrantOptions to Purchase Common Stock · Derivative | 9,768 | Not disclosed Strike: $2.50 | Not disclosed |
DisclosureSEC source: 0001937832-24-000001 · primary_doc.xml · derivative · entry 1 Averilla Reginald · CIK 0001937832 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,768 Underlying: Common Stock · 9,768 shares Expires 2034-04-01 F1 · price: On April 1, 2024, the Reporting Person and the Issuer entered into an agreement whereby the Reporting Person elected to be paid part of his salary in stock options in lieu of cash compensation. These options vest in twelve monthly installments commencing on April 1, 2024 through April 1, 2025. F1 · derivative.exercise_date: On April 1, 2024, the Reporting Person and the Issuer entered into an agreement whereby the Reporting Person elected to be paid part of his salary in stock options in lieu of cash compensation. These options vest in twelve monthly installments commencing on April 1, 2024 through April 1, 2025. Read SEC document |
|
| April 01, 2024 Filed Jul 31, 2024 21:27 UTC |
NICOLS JOHN JDirector
|
GrantOption to Purchase Common Stock · Derivative | 10,778 | Not disclosed Strike: $2.50 | Not disclosed |
DisclosureSEC source: 0001238884-24-000004 · primary_doc.xml · derivative · entry 1 NICOLS JOHN J · CIK 0001238884 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,778 Underlying: Common Stock · 10,778 shares Expires 2034-04-01 F1 · price: On April 1, 2024 the Reporting Person and the Issuer entered into an agreement to elect to be paid for Reporting Person's fees as a Board Director in stock options in lieu of cash compensation. These options vest in twelve (12) monthly installments commencing on April 1, 2024 through April 1, 2025. F1 · derivative.exercise_date: On April 1, 2024 the Reporting Person and the Issuer entered into an agreement to elect to be paid for Reporting Person's fees as a Board Director in stock options in lieu of cash compensation. These options vest in twelve (12) monthly installments commencing on April 1, 2024 through April 1, 2025. Read SEC document |
| April 01, 2024 Filed Aug 2, 2024 20:56 UTC |
SCHUMACHER JURGEN WALTERDirector
|
GrantOption to Purchase Common Stock · Derivative | 14,371 | Not disclosed Strike: $2.50 | Not disclosed |
DisclosureSEC source: 0001987646-24-000001 · primary_doc.xml · derivative · entry 1 SCHUMACHER JURGEN WALTER · CIK 0001987646 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,502 Underlying: Common Stock · 14,371 shares Expires 2034-04-01 F1 · price: On April 1, 2024 the Reporting Person and the Issuer entered into an agreement to elect to be paid for Reporting Person's Board of Director fees in options in lieu of cash compensation. These options vest in twelve monthly installments commencing on April 1, 2024. F1 · derivative.exercise_date: On April 1, 2024 the Reporting Person and the Issuer entered into an agreement to elect to be paid for Reporting Person's Board of Director fees in options in lieu of cash compensation. These options vest in twelve monthly installments commencing on April 1, 2024. Read SEC document |
| January 17, 2024 Filed Jan 29, 2024 17:06 UTC |
SANTOS HELENA RDirector · CEO and President
|
PurchaseWarrants to Purchase Common Stock · Derivative | 11 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001182944-24-000002 · primary_doc.xml · derivative · entry 2 SANTOS HELENA R · CIK 0001286205 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 234,343 Underlying: Common Stock · 11 shares Expires 2029-01-17 F2 · balance_after: Includes 232,366 stock options and 1,977 warrants Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.